Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,026,558
+$199,662 QoQ
Shares Held
21,400
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
6.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lion Point Capital, LP holds $14,988,225 across 30 Biotechnology names. RPRX ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
4,450 | $1,433,745 | |
| 2 | MLTX |
MoonLake Immunotherapeutics
|
67,500 | $1,258,200 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
21,400 | $1,026,558 | |
| 4 | MIST |
Milestone Pharmaceuticals Inc.
|
820,000 | $975,800 | |
| 5 | GERN |
Geron Corp
|
578,000 | $861,220 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
36,000 | $840,960 | |
| 7 | ARDX |
Ardelyx, Inc.
|
128,650 | $770,613 | |
| 8 | FENC |
Fennec Pharmaceuticals Inc.
|
112,434 | $691,469 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,026,558 | 21,400 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $826,896 | 21,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $754,992 | 21,400 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||